Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    MLN-0264
Show Display Options
Rank Status Study
1 Terminated
Has Results
MLN0264 in Previously Treated Asian Participants With Advanced Gastrointestinal Carcinoma or Metastatic or Recurrent Gastric or Gastroesophageal Junction Adenocarcinoma Expressing Guanylyl Cyclase C
Conditions: Advanced Gastrointestinal Carcinoma;   Gastroesophageal Junction Adenocarcinoma;   Recurrent Gastric Adenocarcinoma;   Recurrent Gastroesophageal Junction Adenocarcinoma;   Metastatic Gastric Adenocarcinoma;   Metastatic Gastroesophageal Junction Adenocarcinoma;   Recurrent Gastrointestinal Carcinoma
Intervention: Drug: MLN0264
2 Completed
Has Results
Phase 1 Study of MLN0264 in Adult Patients With Advanced Gastrointestinal Malignancies Expressing Guanylyl Cyclase C
Condition: Advanced Gastrointestinal Malignancies
Intervention: Drug: MLN0264
3 Terminated
Has Results
A Study of MLN0264 in Patients With Pancreatic Cancer
Condition: Pancreatic Adenocarcinoma
Intervention: Drug: MLN0264
4 Terminated
Has Results
A Study of MLN0264 in Participants With Cancer of the Stomach or Gastroesophageal Junction
Conditions: Adenocarcinoma of the Stomach;   Gastroesophageal Junction Expressing Guanylyl Cyclase C
Intervention: Drug: MLN0264

Study has passed its completion date and status has not been verified in more than two years.